Tentative Programme
14th International Leptospirosis Society (ILS) Scientific Meeting 2026
Date: 27–29 October 2026
Venue: Putrajaya Marriott Hotel, Putrajaya, Malaysia
Day 1 — Tuesday, 27 October 2026
Theme 1: Integrated Leptospirosis Control
|
Time |
ID |
Programme |
|
7:30–8:30 AM |
Registration |
|
|
8:30–9:00 AM |
Arrival of Invited Guests and Participants |
|
|
9:00–9:45 AM |
Opening Ceremony National Anthem (Negaraku), UPM Anthem (Putra Gemilang) & Doa Recitation |
|
|
9:45–10:00 AM |
Plenary Address — Leptospirosis in a Changing World: Strengthening Public Health Surveillance and One Health Response |
|
|
10:00–10:15 AM |
Photography Session |
|
|
10:15–10:45 AM |
Coffee Break and Poster Viewing/Evaluation |
|
|
10:45 AM–1:00 PM |
Oral Presentation Session I One Health, Epidemiology and Ecology of Leptospirosis |
|
|
10:45–11:00 AM |
A Pathway to the Future – Bringing a Neglected Disease to the Spotlight One Experiment at a Time Speaker: Dr. Elsio A. Wunder Jr. Associate Professor, Department of Pathobiology and Veterinary Science, College of Agriculture, Health and Natural Resources, University of Connecticut, United States of America. |
|
|
11:00–11:15 AM |
OP015 |
Diversity, ecology, epidemiology, and Leptospira reservoirs Carcauzon Victoria (France) |
|
11:15–11:30 AM |
OP023 |
A Multi-Landscape Assessment of Leptospira Prevalence on a Diversity of Small Mammals Dr. Farah Shafawati Mohd-Taib (Malaysia) |
|
11:30–12:00 PM |
Keynote Address (Google Meet) — Bridging Boundaries: An Integrated One Health Approach to the Control and Management of Leptospirosis in an Endemic State in India Dr. V. Balamurugan, India Principal Scientist-Veterinary Microbiology, WOAH Designated Expert / Head WOAH Reference Laboratory for PPR & Leptospirosis, ICAR-NIVEDI, Karnataka India |
|
|
12:00–12:15 PM |
OP032 |
Leptospira prevalence, cycling, and infection in rural Ecuador Talima Pearson (USA) |
|
12:15–12:30 PM |
OP021 |
A currently unculturable lineage of Leptospira borgpetersenii has infected cattle in multiple U.S. states and is genetically linked to samples from cattle in New Zealand and Uganda Dave Wagner (USA) |
|
12:30–12:45 PM |
OP016 |
Urinary Shedding of Pathogenic Leptospira spp. Across Hosts: A Systematic Review of Reservoirs and Transmission Risk. Gustavo Monti (Netherlands) |
|
12:45–1:00 PM |
OP033 |
Novel Strain of Leptospira interrogans Identified in the Environment Caused Severe Leptospirosis in Berry Farm Workers in California 2024 Nathan E. Stone (USA) |
|
1:00–2:00 PM |
Lunch and Networking |
|
|
2:00–2:30 PM |
Flash Presentation Session I |
|
|
2:00–2:05 PM |
OFP011 |
A Jigsaw Approach to Building One Health Evidence for Leptospirosis in Uganda Lordrick Alinaitwe (Uganda) |
|
2:05–2:10 PM |
OFP012 |
Detection of Leptospira in the Reproductive Tracts and Urine of Female Cull Cattle in Southeastern United States Myranda Gorman (USA) |
|
2:10–2:15 PM |
OFP022 |
Laboratory-confirmed leptospirosis and associated risk factors among undifferentiated febrile illness patients in Jaffna district, Sri Lanka: A hospital-based study Yanuthy Tharsan (Sri Lanka) |
|
2:15–2:20 PM |
OFP016 |
Current Status and Future Challenges of Leptospirosis Hotspots in the Philippines: Recommendation for Policy Development Christopher Allan F. Reballos (Philippines) |
|
2:20–2:25 PM |
OFP008 |
Physicochemical and microbial contexts influence pathogenic Leptospira presence in New Caledonian soils Adriana Luga (New Caledonia) |
|
2:25–2:30 PM |
Q&A |
|
|
2:30–5:30 PM |
Oral Presentation Session II Transmission, Surveillance and Community Action |
|
|
2:30–2:45 PM |
LAWA PH: Strengthening One Health Strategies for Community Leptospirosis Prevention |
|
|
2:45–3:00 PM |
OP014 |
Quantifying under-reporting of leptospirosis in the Taranaki region, New Zealand Julie Collins-Emerson (New Zealand) |
|
3:00–3:15 PM |
OP036 |
A One Health risk stratification model for leptospirosis surveillance using multiple correspondence analysis and hierarchical clustering in Côte d’Ivoire. Koffi Kouadio Stéphane (Côte d'Ivoire) |
|
3:15–3:30 PM |
OP052 |
From an Uncommon Finding to an Emerging Public Health Concern: Two Decades of Leptospira spp. Serogroup Pomona in Croatia Iva Benvin (Croatia) |
|
3:30–3:45 PM |
OP043 |
Twenty-Five Years of Leptospira Surveillance in Costa Rica: Integrating Serology, Genomics, and a Global Perspective on Leptospira santarosai Diana Chinchilla (Costa Rica) |
|
3:45–4:15 PM |
Coffee Break and Poster Viewing/Evaluation |
|
|
4:15–4:30 PM |
OP059 |
Molecular epidemiology of the 2025 leptospirosis surge at San Lazaro Hospital, Manila, the Philippines, by direct multilocus sequence typing. Ryan McCorkell (Japan) |
|
4:30–4:45 PM |
OP054 |
Spatial Epidemiological Approaches to Inform One Health Interventions during Leptospirosis Outbreak in Pangandaran, Indonesia Pandji Wibawa Dhewantara (Indonesia) |
|
4:45–5:00 PM |
OP061 |
Leptospirosis Outbreak Among Crew Members of a Fishing Vessel in Indonesia: Epidemiology, Clinical, Laboratory Findings, Public Health Response Farida Dwi Handayani (Indonesia) |
|
5:00–5:15 PM |
OP064 |
Knowledge, Attitudes, and Practices of Rice Farmers on Leptospirosis in a Rural Municipality in the Philippines Melchor G. Eda Jr. (Philippines) |
|
5:30 PM |
End of Day 1 |
|
|
5:35–7:00 PM |
International MAT Proficiency Testing Discussion (private) |
|
Day 2 — Wednesday, 28 October 2026
Morning Programme
Theme: Integrated Leptospirosis Control — Continued
|
Time |
ID |
Programme |
|
8:00–9:00 AM |
ILS Business meeting (Private) |
|
|
8:00–9:00 AM |
Poster Viewing/Evaluation |
|
|
9:00–10:30 AM |
Oral Presentation Session III |
|
|
9:00–9:15 AM |
A One Health Framework to Understand and Mitigate Climate-driven Leptospirosis in Aotearoa New Zealand Speaker: Dr. Shahista Nisa (New Zealand) |
|
|
9:15–9:30 AM |
OP039 |
Rising in Rural Pahang: Five-year Epidemiological Trends of Leptospirosis in Malaysia, 2021-2025 Dr Widad Ulya Binti Mohamed Yusof (Malaysia) |
|
9:30–9:45 AM |
OP027 |
Spatial clustering and ecological correlates of human leptospirosis in Jaffna, Sri Lanka, from 2019 to 2024 Yanuthy Tharsan (Sri Lanka) |
|
9:45–10:00 AM |
OP011 |
Spatial clustering and environmental correlates of leptospirosis seroprevalence in pregnant women from Anuradhapura, Sri Lanka: An ecological study Shashanka Rajapakse (Sri Lanka) |
|
10:00–10:15 AM |
OP062 |
Population-Based Seroincidence and Leptospiral Infection During Pregnancy in Rural Sri Lanka: The Rajarata Pregnancy Cohort Madushika Sewwandi (Sri Lanka) |
|
10:15–10:30 AM |
OP058 |
Leptospirosis Occurs as Frequently as Malaria Among Acute Febrile Adolescent and Adult Patients in Hoima, Uganda Andrew Vivian Kirabo (Uganda) |
|
10:30–11:00 AM |
Coffee Break and Poster Viewing/Evaluation |
|
|
11:00–1:00 PM |
Oral Presentation Session IV Environmental Risk, Transmission Dynamics and Community Prevention |
|
|
11:00–11:15 AM |
Gamifying Leptospirosis Prevention: From Awareness to Action Speaker: Dr. Syafinaz Amin Nordin (Malaysia) Professor, Medical Microbiology, Faculty of Medicine and Health Sciences, UPM, Malaysia |
|
|
11:15–11:30 AM |
OP030 |
Hydrological and Epidemiological Modeling of Leptospirosis in a Tropical Environment Juan Manuel Cordovez (Colombia) |
|
11:30–11:45 AM |
OP026 |
Study of the environmental impact of leptospirosis in Algeria (2010-2024) Anissa Amara Korba (Algeria) |
|
11:45–12:00 PM |
OP037 |
Environmental Distribution of Pathogenic Leptospira spp. in Subtropical Rivers of Japan Atsuhiro Kanayama (Japan) |
|
12:00–12:15 PM |
OP040 |
Spatially Uniform and Matrix-Independent Distribution of Diverse Leptospira spp. In Estero de Paco, Manila, Philippines Ram Julius L. Marababol (Philippines) |
|
12:15–12:30 PM |
OP063 |
Detection of pathogenic Leptospira, including a new species, across environmental samples in urban and rural settings in the Netherlands Priscyla dos Santos Ribeiro (Netherlands) |
|
12:30–12:45 PM |
OP047 |
Leptospirosis during the 2025 monsoon flood in Sawai Madhopur district, Rajasthan, India: human, environmental and meteorological findings Ankoor Tyagi (India) |
|
12:45–1:00 PM |
OP009 |
Exposure to Leptospira in Munich's Urban River Surfers Martin H. Richter (Germany) |
|
1:00–2:00 PM |
Lunch and Networking |
|
Afternoon
Theme 2: Understanding Disease: Pathogenesis, Clinical Insights and Innovations
|
Time |
ID |
Programme |
|
2:00–2:30 PM |
Keynote Address — Clinical Leptospirosis- the changing phenotype and its impact Dr. Wimalasiri Uluwattage |
|
|
2:30–5:15 PM |
Oral Presentation Session I |
|
|
2:30–2:45 PM |
Clinical Leptospirosis: A Malaysian Perspective Speaker: Dr Yazli Yuhana |
|
|
2:45–3:00 PM |
OP005 |
Clinical Predictors of Fatal Outcomes in Human Leptospirosis, Thailand, 2015-2024 Umaporn Limothai (Thailand) |
|
3:00–3:15 PM |
OP022 |
Qualitative analysis reveals clinical complexities in diagnosing and managing leptospirosis in New Zealand Tanya Maria Quin (New Zealand) |
|
3:15–3:30 PM |
OP013 |
Gene sequence diversity of key pathogen-associated molecular patterns among clinical isolates of Leptospira in Sri Lanka Chamila Kappagoda (Sri Lanka) |
|
3:30–3:45 PM |
OP041 |
Persistence of serological response following leptospirosis - A longitudinal study Dilrukshi Menike (Sri Lanka) |
|
3:45–4:00 PM |
OP053 |
Waning of Naturally Acquired Anti-Leptospira Antibodies During Pregnancy: A Longitudinal Cohort Analysis Janith Warnasekara (Sri Lanka) |
|
4:00–4:30 PM |
Coffee Break and Poster Viewing/Evaluation |
|
|
4:30–4:45 PM |
OP004 |
Chronic sequelae following leptospirosis in Aotearoa New Zealand: a nationwide cohort study Shahista Nisa (New Zealand) |
|
4:45–5:00 PM |
OP055 |
Direct and Indirect Costs Incurred by Clinically Diagnosed Leptospirosis Patients Admitted to the Teaching Hospital, Anuradhapura, Sri Lanka Manojika Jayasinghe (Sri Lanka) |
|
5:00-5:15 PM |
OP056 |
Role of N-Acetylcysteine in Targeting Tubular Injury and Oxidative Stress in Leptospirosis: A Randomized Placebo-Controlled Trial Selfie Bustaman Zainuddin F (Indonesia) |
|
5:15–6:05 PM |
Flash Presentation Session II |
|
|
5:15–5:20 PM |
OFP010 |
Leptospirosis: A Leading Identified Cause of Acute Undifferentiated Fever Presenting as Community-acquired Sepsis at Udon Thani Hospital, Thailand Atiwit Loucharoen (Thailand) |
|
5:20–5:25 PM |
OFP007 |
Development of a Gold Nanoparticle-Based Electrochemical Aptasensor for Rapid Detection of Pathogenic Leptospira in Canine Urine. Nouraldin K.N Houbri (Thailand) |
|
5:25–5:30 PM |
OFP013 |
Characterization of Epithelial and Endothelial Junctional Proteins in Human Leptospirosis and Experimental Models of Leptospira Infection Milena Carvalho Carneiro (Brazil) |
|
5:30–5:35 PM |
OFP014 |
Participation of the Complement System in Experimental Leptospirosis-Associated Pulmonary Hemorrhagic Syndrome Lara Rodrigues da Silva (Brazil) |
|
5:35–5:40 PM |
OFP021 |
Whole-Genome Sequencing and Pathogenicity Characterization Reveal the Virulence of Leptospira interrogans Isolated from a Greater Bandicoot Rat (Bandicota indica) in a Leptospirosis Hotspot of Southern India Prajakta Prashant Bokade (India) |
|
5:40–5:45 PM |
OFP005 |
Phylogenetic and functional evolution of copper homeostasis systems in Leptospira: evidence for a regulator switch between CueR and CsoR Gregoire Davignon (New Caledonia) |
|
5:45–5:50 PM |
OFP003 |
Transcriptional Regulatory Model of Biofilm-Associated Regulons in Leptospira biflexa Larissa Vasconcelos (Brazil) |
|
5:50–6:05 PM |
Q&A |
|
Day 3 — Thursday, 29 October 2026
Morning Programme
Understanding Disease: Pathogenesis, Clinical Insights & Innovations — Continued
|
Time |
ID |
Programme |
|
8:30–10:30 AM |
Oral Presentation Session II Pathogenesis, Host Adaptation and Immune Responses |
|
|
8:30–8:45 AM |
OP025 |
Deciphering Host Adaptation and Virulence Mechanisms in Leptospira interrogans Mathieu Picardeau (France) |
|
8:45–9:00 AM |
OP020 |
Role of NLRP3 activation in host-specific immune responses against Leptospira interrogans David A. Haake (USA) |
|
9:00–9:15 AM |
OP045 |
Expansion of WC1⁺CD8⁺ γδ T cells, upregulation of immune effector and activation genes, together with reduced CD14⁺ monocyte responses, characterize immunity in cattle experimentally challenged with Leptospira kirschneri serovar Grippotyphosa Marcella Mori (Belgium) |
|
9:15–9:30 AM |
OP018 |
Signaling and regulatory network for host adaptation in Leptospira Nadia BENAROUDJ (France) |
|
9:30–9:45 AM |
OP019 |
Distinct Molecular Trajectories Underlie a Shared Lethal Outcome in Experimental Acute Leptospirosis Sreekumari Rajeev (USA) |
|
9:45–10:00 AM |
OP057 |
Deciphering the C-degron tag encoded by a small stable RNA A (SsrA) in facilitating protein degradation by the Leptospira interrogans caseinolytic protease machinery ClpAP1P2 Kumar Manish (India) |
|
10:00–10:15 AM |
OP049 |
Systems Biology Reveals the Central Role of Glucose in Leptospira Adaptation to Host Temperature Ryo Ozuru (Japan) |
|
10:15–10:30 AM |
OP003 |
Proteasome-dependent aberrant collective cell migration in Leptospira-infected renal epithelial cells Claudia Toma (Japan) |
|
10:30–11:00 AM |
Coffee Break and Poster Viewing/Evaluation |
|
|
11:00AM–12:00PM |
ILS Meeting |
|
Theme 3: Current and Next-Generation Tools for Leptospirosis: Diagnostics, Therapies and Vaccines
|
Time |
ID |
Programme |
|
12:00–12:30 PM |
Keynote Address — Immune cell responses to Leptospira infection in the murine host |
|
|
12:30–1:00 PM |
Oral Presentation Session I |
|
|
12:30–12:45 PM |
Leptospirosis diagnostic capacity in Malaysia: From History to Integrative Genomic and Serological Tools Speaker: Dr. Murnihayati Hassan (Malaysia) |
|
|
12:45–1:00 PM |
OP010 |
When the Reference Standard Is Imperfect: A Comparative Evaluation of IgM ELISA and MAT for Leptospirosis Diagnosis Shikha Tiwari (India) |
|
1:00–2:00 PM |
Lunch and Networking |
|
|
2:00–2:50 PM |
Flash Presentation Session III |
|
|
2:00–2:05 PM |
OFP004 |
Development and validation of a multiplex real-time PCR assay for simultaneous detection and speciation of pathogenic Leptospira in New Zealand Stuart Littlejohn (New Zealand) |
|
2:05–2:10 PM |
OFP017 |
Expanding the Diagnostic Toolbox for High-Throughput Bovine Leptospirosis Diagnosis: Belgian Case-Control Validation of Competitive ELISAs for Grippotyphosa and Australis Serovars Michaël Van Nimmen (Belgium) |
|
2:10–2:15 PM |
OFP002 |
Validating a simple score to predict severe leptospirosis Patrick Rosengren (Australia) |
|
2:15–2:20 PM |
OFP006 |
Dissecting cell surface protein diversity to enhance leptospiral vaccine efficacy Abbie Hinds (United Kingdom) |
|
2:20–2:25 PM |
OFP009 |
Integrative In silico and In vitro approaches toward a Multi-Epitope Subunit Vaccine against Leptospirosis Jemima John, Bhairavi Balasubramanian (India) |
|
2:25–2:30 PM |
OFP020 |
Efficacy and safety treatment outcomes of importance to patients and healthcare providers for a future leptospirosis trial: A qualitative study Nathaniel Lee (Japan) |
|
2:30–2:35 PM |
OFP023 |
A Next-Generation Multi-Epitope Vaccine Against Leptospirosis: From Molecular Characterization to Immune Activation Bothammal Palanisamy (India) |
|
2:35–2:50 PM |
Q&A |
|
|
2:50–4:35 PM |
Oral Presentation Session I continued |
|
|
2:50–3:05 PM |
OP060 |
Evaluation of five Leptospira real-time PCR assays widely used for diagnostics Ahmed Ahmed Ahmed (Netherlands) |
|
3:05–3:20 PM |
OP024 |
Development of Diagnostic Peptides leveraging Multi-Stage Subtractive Proteomics-driven Target Selection for early detection of Leptospirosis Sambandam Ravikumar (India) |
|
3:20–3:35 PM |
OP029 |
Aptamer Based Molecular Diagnostic methods for Leptospirosis M. Ramya (India) |
|
3:35–3:50 PM |
OP031 |
Deciphering Leptospira-Host Interactions through Integrated Multi-omics: From Virulence Factor Discovery to Vaccine Design Syed M. Faisal (India) |
|
3:50-4:05 PM |
OP065 |
Advancing Subunit Vaccine Development for Leptospirosis through Optimized Outer Membrane Protein Antigen Production Azira Muhamad (Malaysia) |
|
4:05–4:20 PM |
OP044 |
Development of a core outcome and measurement set for international leptospirosis trials (COS-LEP) Nathaniel Lee (Japan) |
|
4:20–4:35 PM |
OP051 |
β-lactam antibiotics trigger TLR-dependent Jarisch-Herxheimer reaction in leptospirosis Catherine Werts (France) |
|
4:35–4:50 PM |
OP046 |
Multi-omics insights into biofilm reprogramming and biosynthetic persistence in the intermediate (P2) species Leptospira fainei K. Vinod Kumar (India) |
|
4:50–5:15 PM |
Day 3 Wrap-Up, Closing Remarks and Awards |
|
|
5:15 PM |
Coffee Break and Departure |
|
Programme at a Glance
Theme 1: Integrated Leptospirosis Control
Session I – One Health, Epidemiology and Ecology of Leptospirosis
Session II – Transmission, Surveillance and Community Action
Session III – Human Epidemiology, Clinical Disease and Population Risk
Session IV – Environmental Risk, Transmission Dynamics and Community Prevention
Theme 2: Understanding Disease – Pathogenesis, Clinical Insights and Innovations
Session I — Clinical Disease, Outcomes and Long-Term Impact
Session II — Pathogenesis, Host Adaptation and Immune Responses
Theme 3: Current and Next-Generation Tools for Leptospirosis: Diagnostics, Therapies and Vaccines
Note: The program is subject to change due to the finalization of speakers’ attendance. Participants will be duly informed of any changes.
